An Evaluation of the Prescription of Opioids for Chronic Nonmalignant Pain by Australian General Practitioners

Pain Medicine (United States)

Volumn 14, Issue 1, 2013, Pages 62-74

  Holliday, Simon ^a,b   Magin, Parker ^c   Dunbabin, Janet ^c   Oldmeadow, Christopher ^d   Henry, Julie Marie ^a   Lintzeris, Nicholas ^e,f   Attia, John ^d,g   Goode, Susan ^c   Dunlop, Adrian ^a,c  

^a Albert St Medical Centre   (Australia)

^b Drug and Alcohol Clinical Services   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Addiction; Opioids; Pain management; Primary care; Quality of health care

Indexed keywords

OPIATE;

ADULT; ANALGESIA; ARTICLE; AUSTRALIA; CHRONIC NONMALIGNANT PAIN; CHRONIC PAIN; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MALE; MEDICAL EDUCATION; OPIATE SUBSTITUTION TREATMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE; REGISTRATION; SEX DIFFERENCE;

EID: 84872494647     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01527.x     Document Type: Article

References (62)

1. Royal Australasian College of Physicians. Prescription Opioid Policy: Improving Management of Chronic Non-Malignant Pain and Prevention of Problems Associated with Prescription Opioid Use. Sydney, Australia: The Royal Australasian College of Physicians; 2009.
2. Ballantyne JC, Fleisher LA. Ethical issues in opioid prescribing for chronic pain. Pain 2010;148(3):365-367.
3. Ballantyne JC. Palliative care: Not only for the dying: Care at the close of life: Evidence and experience (JAMA evidence). Clin J Pain 2012;28(5):463. doi:10.1097/AJP.0b013e31823984cb.
4. Halliday R. Management of the narcotic addict. B C Med J 1963;5(10):412-414.
5. Weiss RD, Potter JS, Fiellin DA, etal. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Arch Gen Psychiatry 2011;68(12):1238-1246.
6. Cousins MJ, Lynch ME. The Declaration Montreal: Access to pain management is a fundamental human right. Pain 2011;152(12):2673-2674.
7. Washington State Agency Medical Directors' Group. Interim evaluation of the Washington State interagency guideline on opioid dosing for chronic non-cancer pain. Department of Labor and Industries, editor. Washington State, 2009.
8. Lippe PM, Brock C, David J, Crossno R, Gitlow S. The first national pain medicine summit-Final summary report. Pain Med 2010;11(10):1447-1468.
9. Krashin D, Murinova N, Ballantyne J. Management of pain with comorbid substance abuse. Curr Psychiatry Rep 2012;14(5):462-468.
10. Chapman C, Lipschitz D, Angst M, etal. Opioid pharmacotherapy for chronic non-cancer pain in the united states: A research guideline for developing an evidence-base. J Pain 2010;11(9):807-829.
11. Ballantyne JC. Is lack of evidence the problem? J Pain 2010;11(9):830-832.
12. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. J Pain 2009;10(2):147-59.e15.
13. Fauber J. Chronic pain fuels boom in opioids. MedPage Today, 2012. Available at: http://www.medpagetoday.com/Neurology/PainManagement/31254 (accessed 9/3/11).
14. Boulanger A, Clark A, Squire P, Cui E, Horbay G. Chronic pain in Canada: Have we improved our management of chronic noncancer pain? Pain Res Manag 2007;12(1):39-47.
15. Portenoy RK, Farrar JT, Backonja M-M, etal. Long-term use of controlled-release oxycodone for noncancer pain: Results of a 3-year registry study. Clin J Pain 2007;23(4):287-299.
16. Ballantyne JC. U.S. opioid risk management initiatives. Pain Clin Updates 2009;17(6):1-5. Available at: http://www.iasp-pain.org/AM/AMTemplate.cfm?Section=HOME&CONTENTID=10419&SECTION=HOME&TEMPLATE=/CM/ContentDisplay.cfm (accessed 19/11/11).
17. Ballantyne JC. Pain medicine: Repairing a fractured dream. Anesthesiology 2011;114(2):243-246.
18. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: A ten-year perspective. Pain Physician 2010;13(5):401-435.
19. Ballantyne JC. Opioid controls: Regulate to educate. Pain Med 2010;11(4):480-481.
20. Wenghofer EF, Wilson L, Kahan M, etal. Survey of Ontario primary care physicians' experiences with opioid prescribing. Can Fam Physician 2011;57(3):324-332.
21. Lucas CE, Vlahos AL, Ledgerwood AM. Kindness kills: The negative impact of pain as the fifth vital sign. J Am Coll Surg 2007;205(1):101-107.
22. Zgierska A, Miller M, Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA 2012;307(13):1377-1378.
23. Office of National Drug Control Policy. Epidemic: Responding to America's prescription abuse crisis: Executive office of the president of the United States. 2011 Contract No. Available at: http://www.whitehouse.gov/sites/default/files/ondcp/issues-content/prescription-drugs/rx_abuse_plan_0.pdf (accessed September 15, 2012).
24. Holmes D. Prescription drug addiction: The treatment challenge. Lancet 2012;379(9810):17-18.
25. Warner M, Chen L, Makuc D, Anderson R, Miniño A. Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief. Statistics NCfH, editor. Hyattsville, MD, 2011.
26. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 1999-2009. State admissions to substance abuse treatment services. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. Contract No.: DASIS Series S-58, HHS Publication No. (SMA) 11-4663.
27. Tavernise S. Life spans shrink for least-educated whites in the U.S. The New York Times, September 20, 2012.
28. Green TC, Black R, Grimes Serrano JM, Budman SH, Butler SF. Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. Plos One 2011;6(11):e27244.
29. Ballantyne JC. Chronic opioid therapy and its utility in different populations. Pain 2012. [Epub ahead of print].
30. Becker WC, Starrels JL, Heo M, etal. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med 2011;9(3):219-225.
31. Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007;129(3):235-255.
32. Dunn KM, Saunders KW, Rutter CM, etal. Opioid prescriptions for chronic pain and overdose. Ann Intern Med 2010;152(2):85-92.
33. Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: An epidemiological study. Pain 2006;125(1-2):172-179.
34. Franklin G, Rahman E, Turner J, Daniell W, Fulton-Kehoe D. Opioid use for chronic low back pain: A prospective, population-based study among injured workers in Washington state, 2002-2005. Clin J Pain 2009;25(9):743-751.
35. Harrison CM, Charles J, Henderson J, Britt H. Opioid prescribing in Australian general practice. Med J Aust 2012;196(6):380-381.
36. AIHW, Australian GP Statistics and Classification Centre. SAND abstract no. 150 from the BEACH program: Chronic pain in general practice patients. Sydney AGPSCC, University of Sydney, 2010.
37. Roxburgh A, Burns L. Accidental Opioid-Induced Deaths in Australia 2008. Sydney: National Drug and Alcohol Research Centre, UNSW; 2012.
38. Chou R. Using evidence in pain practice: Part I: Assessing quality of systematic reviews and clinical practice guidelines. Pain Med 2008;9(5):518-530.
39. Corson K, Doak MN, Denneson L, etal. Primary care clinician adherence to guidelines for the management of chronic musculoskeletal pain: Results from the study of the effectiveness of a collaborative approach to pain. Pain Med 2011;12(10):1490-1501.
40. Franklin GM, Mai J, Turner J, etal. Bending the prescription opioid dosing and mortality curves: Impact of the Washington State opioid dosing guideline. Am J Ind Med 2012;55(4):325-331.
41. Hunter Integrated Pain Service. Opioid quick steps: Opioid prescribing for persistent pain, 2010. Available at: http://www.hnehealth.nsw.gov.au/pain/health_professionals/medical_practice_guidelines (accessed March 9, 2010).
42. Hayes C, Hodson FJ. A whole-person model of care for persistent pain: From conceptual framework to practical application. Pain Med 2011;12(12):1738-1749.
43. AIHW. National opioid pharmacotherapy statistics annual data collection: 2011 report. 2012. Canberra AIHW 2012-Contract No.: PHE 161.
44. Lewis ET, Combs A, Trafton JA. Reasons for under-use of prescribed opioid medications by patients in pain. Pain Med 2010;11(6):861-871.
45. Hurwitz W. The challenge of prescription drug misuse: A review and commentary. Pain Med 2005;6(2):152-161.
46. Layne RD, Pellegrino RJ, Lerfald NM. Prescription opioids and overdose deaths. JAMA 2009;301(17):1766-a-7.
47. Passik SD, Hays L, Eisner N, Kirsh KL. Psychiatric and Pain characteristics of prescription drug abusers entering drug rehabilitation. J Pain Palliat Care Pharmacother 2006;20(2):5-13.
48. Johnson TP, Booth AL, Johnson P. Physician beliefs about substance misuse and its treatment: Findings from a U.S. survey of primary care practitioners. Subst Use Misuse 2005;40(8):1071-1084.
49. Wilkens JR, Belgrade MJ. Do pain specialists meet the needs of the referring physician? A survey of primary care providers. J Opioid Manag 2008;4(1):13-20.
50. Slevin KA, Ashburn MA. Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies. J Opioid Manag 2011;7(2):109-115.
51. McLellan AT, Turner BJ. Chronic noncancer pain management and opioid overdose: Time to change prescribing practices. Ann Intern Med 2010;152(2):123-124.
52. Murphy JL, Clark ME, Banou E. Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment. Clin J Pain 2012. doi:10.1097/AJP.0b013e3182579935.
53. AIHW. Medical Workforce 2010. Canberra: AIHW; 2012: Available at: http://www.aihw.gov.au/publication-detail/?id=10737421480 (accessed April 1, 2012).
54. Kircher S, Zacny J, Apfelbaum SM, etal. Understanding and treating opioid addiction in a patient with cancer pain. J Pain 2011;12(10):1025-1031.
55. Edlund MJ, Martin BC, Fan M-Y, etal. An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study. J Pain Symptom Manage 2010;40(2):279-289.
56. Swedlow A, Ireland J, Johnson G. Prescribing patterns of schedule II opioids in California Workers' Compensation Oakland, CA, 2011. Cal. Workers' Compensation Update. Mar 1-12. Available at: http://www.cwci.org/research.html (accessed October 9, 2012).
57. Smith DE. Prescribing practices and the prescription drug epidemic: Physician intervention strategies. J Psychoactive Drugs 2012;44(1):68-71.
58. O'Brien C. Addiction and dependence in DSM-V. Addiction 2011;106(5):866-867.
59. Hannah J. Lawyer says client is a target. The Cincinnati Enquirer, September 26, 2012. Available at: http://news.cincinnati.com/article/20120926/NEWS010704/309260129/Lawyer-says-client-target?odyssey=tab|topnews|text|FRONTPAGE (accessed October 9, 2012).
60. Brown J, Setnik B, Lee K, etal. Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting. J Pain Res 2011;4:373-384.
61. Britt H, Miller G, Charles J, etal. General Practice Activity in Australia 2009-10. Canberra: AIHW; 2010. Available from: http://www.aihw.gov.au/publication-detail/?id=6442472433&tab=2 (accessed 1/11/11).
62. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2011. ISBN 3-900051-07-0, URL http://www.R-project.org/.